Gyre Therapeutics
GYRE
#5532
Rank
A$1.54 B
Marketcap
$18.03
Share price
-8.99%
Change (1 day)
-7.11%
Change (1 year)

Gyre Therapeutics (GYRE) - Cash on Hand

Cash on Hand as of June 2024 : A$38.51 Million

According to Gyre Therapeutics's latest financial reports the company has A$38.51 Million in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Gyre Therapeutics - Cash on Hand chart (from 2024 to 2023)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31A$49.18 M816.93%
2022-12-31A$5.36 M-6.41%
2021-12-31A$5.73 M